You have 9 free searches left this month | for more free features.

Local Ablative Therapies

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adenocarcinoma, Stomach Tumor, Gastroesophageal-junction Cancer Trial in Shanghai (radiation, biological, drug, procedure)

Recruiting
  • Adenocarcinoma
  • +8 more
  • Radiotherapy targeted to the primary lesion
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Nov 7, 2023

Colorectal Cancer, Oligometastatic Disease Trial in Australia (Local Ablative Therapy, Standard first-line systemic treatment)

Recruiting
  • Colorectal Cancer
  • Oligometastatic Disease
  • Local Ablative Therapy
  • Standard first-line systemic treatment
  • Albury, New South Wales, Australia
  • +8 more
May 15, 2023

Prostate Cancer, Oligoprogressive, Urothelial Carcinoma Trial in Sacramento (Ablative local therapy)

Recruiting
  • Prostate Cancer
  • +3 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 19, 2023

Breast Cancer, Oligoprogressive, Head Neck Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Breast Cancer
  • +4 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 19, 2023

NSCLC, Oligoprogressive, Small-cell Lung Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Esophageal Cancer, Small Bowel Cancer, Gastroesophageal-junction Cancer Trial in Sacramento (Ablative local therapy)

Recruiting
  • Esophageal Cancer
  • +10 more
  • Ablative local therapy
  • Sacramento, California
    University of California, Davis
Oct 27, 2023

Lung Adenocarcinoma, Lung Tumors Trial run by the NCI (osimertinib, LAT)

Completed
  • Lung Adenocarcinoma
  • Lung Neoplasms
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 17, 2022

Prostate Cancer Trial in Dallas (Ablative Therapy)

Not yet recruiting
  • Prostate Cancer
  • Ablative Therapy
  • Dallas, Texas
    UTSW
Jul 25, 2022

Renal Cancer Trial in Calgary, Edmonton

Recruiting
  • Renal Cancer
    • Calgary, Alberta, Canada
    • +1 more
    Apr 5, 2022

    NSCLC (NSCLC), Stage IV Trial in Switzerland (Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy),

    Not yet recruiting
    • Non-small Cell Lung Cancer (NSCLC)
    • Stage IV
    • Systemic therapy alone or in combination with LAT (surgery and/or radiotherapy)
    • +2 more
    • Aarau, Switzerland
    • +7 more
    Oct 27, 2023

    Breast Cancer Invasive, Metastatic Cancer, Oligoprogressive Trial in Amsterdam (procedure, radiation, other)

    Not yet recruiting
    • Breast Cancer Invasive
    • +2 more
    • Surgery
    • +2 more
    • Amsterdam, Netherlands
      Antoni van Leeuwenhoek
    Mar 21, 2022

    NSCLC, Metastatic Non Small Cell Lung Cancer, Nsclc Trial in United States (Local ablative therapy, Blood collection to assess

    Recruiting
    • Non-small Cell Lung Cancer
    • +5 more
    • Local ablative therapy
    • Blood collection to assess for ctDNA
    • Basking Ridge, New Jersey
    • +6 more
    Jun 20, 2022

    Biliary Tract Tumors, Liver Cancer, Hepatocellular Carcinoma Trial run by the NCI (Durvalumab, Tremelimumab, Trans-arterial

    Active, not recruiting
    • Biliary Tract Neoplasms
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Mar 1, 2022

    Brain Metastases, Adult Trial in Leuven (Stereotactic radiotherapy)

    Recruiting
    • Brain Metastases, Adult
    • Stereotactic radiotherapy
    • Leuven, Belgium
      UZLeuven
    Oct 21, 2021

    Prostate Cancer Metastatic Trial in Canada (Ablative Radiation Therapy, Standard of care)

    Recruiting
    • Prostate Cancer Metastatic
    • Ablative Radiation Therapy
    • Standard of care
    • Victoria, British Columbia, Canada
    • +14 more
    Nov 14, 2022

    Locally Advanced Non Small Cell Lung Cancer, Metastatic Non Small Cell Lung Cancer Trial in France (SRT, Immunotherapy)

    Recruiting
    • Locally Advanced Non Small Cell Lung Cancer
    • Metastatic Non Small Cell Lung Cancer
    • Angers, France
    • +4 more
    Apr 21, 2022

    Oligometastatic Disease, Prostatic Cancer, Castration-Resistant Trial in Dresden (local ablative radiotherapy)

    Recruiting
    • Oligometastatic Disease
    • Prostatic Cancer, Castration-Resistant
    • local ablative radiotherapy
    • Dresden, Saxony, Germany
      Department of Radiotherapy and Radiation Oncology, Faculty of Me
    Aug 18, 2021

    Colorectal Cancer, Adjuvant Chemo Trial in Guangzhou (wait and watch, adjuvant chemo)

    Recruiting
    • Colorectal Cancer
    • Adjuvant Chemotherapy
    • wait and watch
    • adjuvant chemotherapy
    • Guangzhou, Guangdong, China
      Sixth Affiliated Hospital of Sun Yat-sen University
    Jan 25, 2022

    Gastric Cancer Trial in Beijing (RC48-ADC, Herceptin, Toripalimab)

    Not yet recruiting
    • Gastric Cancer
    • Beijing, China
      Beijing Cancer Hospital
    Aug 7, 2023

    NSCLC With Mutation in Epidermal Growth Factor Receptor Trial in Leuven (Local ablative therapy)

    Recruiting
    • Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor
    • Local ablative therapy
    • Leuven, Belgium
      UZLeuven
    Oct 21, 2021

    Advanced Gastric Cancer Trial in Worldwide (Nivolumab, Ipilimumab, Relatlimab)

    Active, not recruiting
    • Advanced Gastric Cancer
    • Nivolumab
    • +4 more
    • Phoenix, Arizona
    • +34 more
    Aug 18, 2022

    NSCLC Trial in Worldwide (MORAb-202)

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
    • Lone Tree, Colorado
    • +21 more
    Jan 17, 2023

    CirculAting Tumor DNA in Patients DIagnosed With Lung Metastasis

    Not yet recruiting
    • Colorectal Cancer
    • Lung Metastases
    • Diagnostic Test: liquid biopsy
    • Seoul, Korea, Republic of
      Department of Laboratory Medicine, Yonsei University College of
    Jan 11, 2021

    Post Prostatectomy Trial in Toronto ([18F]DCFPyL PET/MRI scan, Stereotactic Ablative Radiotherapy)

    Recruiting
    • Post Prostatectomy
    • [18F]DCFPyL PET/MRI scan
    • Stereotactic Ablative Radiotherapy
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Dec 31, 2021

    Carcinoma, NSCLC Trial in Worldwide (nivolumab, ipilimumab, cabozantinib)

    Withdrawn
    • Carcinoma, Non-small Cell Lung Cancer
    • nivolumab
    • +5 more
    • Detroit, Michigan
    • +22 more
    Mar 8, 2022